The cytoplasmic sequence of E‐cadherin promotes non‐amyloidogenic degradation of Aβ precursors
The presenilin (PS)/γ‐secretase system promotes production of the Abeta (Aβ) peptides by mediating cleavage of amyloid precursor protein (APP) at the γ‐sites. This system is also involved in the processing of type‐I transmembrane proteins, including APP, cadherins and Notch1 receptors, at the ɛ‐clea...
Saved in:
Published in: | Journal of neurochemistry Vol. 96; no. 4; pp. 1182 - 1188 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Oxford, UK
Blackwell Science Ltd
01-02-2006
Blackwell |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The presenilin (PS)/γ‐secretase system promotes production of the Abeta (Aβ) peptides by mediating cleavage of amyloid precursor protein (APP) at the γ‐sites. This system is also involved in the processing of type‐I transmembrane proteins, including APP, cadherins and Notch1 receptors, at the ɛ‐cleavage site, resulting in the production of peptides containing the intracellular domains (ICDs) of the cleaved proteins. Emerging evidence shows that these peptides have important biological functions, raising the possibility that their inhibition by γ‐secretase inhibitors may be detrimental to the cell. Here, we show that peptide E‐Cad/CTF2, produced by the PS1/γ‐secretase processing of E‐cadherin, promotes the lysosomal/endosomal degradation of the transmembrane APP derivatives, C99 and C83, and inhibits production of the APP ICD (AICD). In addition, E‐Cad/CTF2 decreases accumulation of total secreted Aβ. These data suggest a novel method to promote the non‐amyloidogenic degradation of Aβ precursors and to inhibit Aβ production. |
---|---|
Bibliography: | The present address of Rosa Miñana Muros is Departamento Patologia Celular Centro de Investigation Principe Felipe, Valencia 46013, Spain. The present address of Georgia Agiostratidou is Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA. The present address of Philippe Marambaud is Litwin‐Zucker Center for Alzheimer's Disease Research, North Shore‐LIJ Institute for Medical Research, Manhasset, New York, NY, USA. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0022-3042 1471-4159 |
DOI: | 10.1111/j.1471-4159.2005.03616.x |